Researchers assessed the association of KRAS mutations in metastatic PDAC with the clinical outcomes and responses to first-line chemotherapy regimens.

Findings from a multi-institutional, international study have significantly advanced the understanding of genetic alterations in the BRCA2 gene, a key player in hereditary cancer risk.

Antigen-independent single-cell circulating tumor cell detection using deep-learning-assisted biolasers - ...

Life without a pancreas involves treatments to replace organ function. Learn how different surgical techniques affect overall ...